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1. Introduction
The aging processes proceed in small steps making it difficult to separate aging symptoms
from early pathological processes. Cell metabolism involves metal ions and trace elements
together with compounds necessary for optimal function. In case of imbalance in cells both
compounds and distribution of metal ions may be changed but the change of metal ions and
trace elements may probably be easier to identify than the large quantity of metabolized
compounds. In cells there are distributions of elements, an elemental profile, indicating normal
metabolism. Brain has a high demand of oxygen supply and need optimal supply of protection
of reactive products. The erythrocytes pass brain many times and other organs accumulating
information of elements during their way. We have chosen erythrocytes because oxygen
dependent cells need regular supply of oxygen for a stable metabolism. Erythrocytes collect
information for about 120 days and then will be replaced by new cells. Elemental profiles of
erythrocytes reflect information in their own metabolism (limited metabolism) but may also
give important information from other cells by deviations in the homeostasis, the element
profile. For monitoring elemental profiles of the erythrocytes we have used inductively
coupled plasma mass spectrometry (ICP-MS) which is selective, sensitive and allow analysis
of elements in low concentration in a short time.
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2. Material and methods
2.1. Patients
Thirteen diagnosed Alzheimer patients, 9 men and 4 women (mean age 61 y) and age matched
controls (mean age 58 y) were selected for the study living in the same area. All patients
participated voluntarily according to Helsinki declaration.
2.2. Samples
Whole blood (2x7 ml) was drawn into Vacutainer tubes for trace element analysis (BDH, with
sodium heparin as anticoagulant). Centrifugation was started half an hour after venopuncture.
The erythrocytes were separated by centrifugation at 120xg at 4 C for 15 minutes. After
removing the buffy coat the erythrocytes were washed twice with 0.9 % NaCl at 1000xg for 5
minutes. The erythrocytes were transferred to cryo vials (Nunc) weighed and freezed at-18 C.
The samples (0.6-0.8g, wet weight) were digested with nitric acid and hydrogen peroxide (both
ultra pure) in microwave oven. The samples were diluted with Milli-Q water in 25 ml poly‐
propylene bottles.
2.3. ICP-MS instrumentation
For the elemental analysis of the erythrocytes ICP-MS, Elan 6100 DRC was used in peak
hopping mode. The isotopes monitored: 107Ag, 114Cd, 208Pb and 238U. Integration time: 5 sweep,
100 msek. Internal standard 10 ppb Rh was supplied by externally feeding. 114Cd was corrected
for 114Sn. The analytical technique used is described in more details [1, 2, 3].
2.4. Reagents and standards
Ultra pure nitric acid and hydrogen peroxide was obtained from Merck. ICP-MS standards
were obtained from Johnson & Matthey, SRM 1566a and 1577a from NIST. The different
isotopes were validated against Oyster tissue 1566a, Bovine liver 1577a.
The estimated accumulated mean error in the analysis of samples was ± 10 % or less generated
in the sampling procedure, preparation, digestion, volumetric and weighing errors and error
in the ICP-MS analysis. For statistical calculations of ICP-MS results Wilcoxon’s nonparametric
test was used.
3. Results
3.1. Elemental profiles of erythrocytes
The main transport of erythrocytes is oxygen from the lungs to cells and carbon dioxide back
to lungs serving different organs including brain. The elemental profile of the erythrocytes
reflect metabolism of oxygen supplied cells but also the metabolism of the erythrocyte itself.
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As erythrocytes carry ferro ions in hemoglobin and other divalent elements e.g. zinc, magne‐
sium, calcium they will also reflect external influence of metabolism. The elemental profile of
erythrocytes will be a status report of cell metabolism translated in terms of metal ions and
trace elements. In this study we report accumulated ions: silver, cadmium, lead and uranium
in the erythrocytes of patients with Alzheimer’s disease. The concentration of lead (wet weight)
in the erythrocytes of patients with Alzheimer’s disease is demonstrated in Figure 1. The result
of cadmium analysis (wet weight) of the erythrocytes is shown in Figure 2. The concentration
of silver in the erythrocytes is indicated in Figure 3. The concentration of uranium in the
erythrocytes was significant higher that of controls Figure 4. In summary the concentrations
of Pb, Cd, Ag and U were significant higher than those of controls.
Figure 1. Lead concentration in erythrocytes of 13 patients with Alzheimer’s disease. Patient 1-9 men, 10-13 women.
Error bar 10%. The mean value of Pb in Alzheimer’s patients was 157 μg/kg, mean of controls 31 μg/kg, standard
error 52.8 μg/kg. Pb increases normally with age but the Alzheimer group indicate significant (Wilcoxon, p< 0.005)
higher accumulation.
Figure 2. Distribution of cadmium in erythrocytes of 13 patients with Alzheimer’s disease. Patient 1-9 men, 10-13
women. Error bar 10%. The mean value of Cd in Alzheimer’s patients was 11.5 μg/kg, standard error 3.9 μg/kg, mean
of controls 1.3 μg/kg, The concentration of Cd in the erythrocytes of patients with Alzheimer’s disease was significant
higher (Wilcoxon, p< 0.05) than that of controls.
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Figure 3. Distribution of silver in erythrocytes of 13 patients with Alzheimer’s disease. Patient 1-9 men, 10-13 women.
Error bar 10%. The mean value of Ag in Alzheimer’s patients was 7.4 μg/kg, standard error 1.5 μg/kg, mean of con‐
trols 1.3 μg/kg, The concentration of silver in the erythrocytes of patients was significant higher (Wilcoxon, p< 0.005)
than that of controls.
Figure 4. Concentration of uranium in erythrocytes of 13 patients with Alzheimers disease. Patient 1-9 men, 10-13
women. Error bar 10 %. The mean value of U in Alzheimer’s patients was 0.55 μg/kg, standard error 0.16 μg/kg, mean
of controls 0.11 μg/kg, The concentration of uranium in the erythrocytes of patients with Alzheimer’s disease was sig‐
nificant higher (Wilcoxon, p<0.01) than that of controls
4. Discussion
Brain has low storing capacity of oxygen though it is a demanding consumer: brain uses about
20 % of oxygen total supply. In degenerative diseases like Alzheimer’s, Parkinson’s disease
the etiology often are not fully known. In Alzheimer’s disease pathophysiological theories have
been proposed e.g. heat shock protein interactions [4], Tau-protein abnormality [5] neuroin‐
flamation and neuronal loss [6, 7], β-amyloid interactions [8], mitochondrial misfunction [9].
An overlooked possibility may be using ICP-MS for analysis of elemental profiles of erythro‐
cytes as biomarker for Alzheimer ‘s disease. Small changes in metabolism of oxygen dependent
cells may give symptoms difficult to identify due to lack of suitable biomarkers [10, 11, 12. 13,
14]. Erythrocytes carrying excess lead, cadmium, silver and uranium ions may induce damages
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in cells including brain cells. Accumulation of elements in the human erythrocytes are a result
of low exposure and not of a sudden insult which calls for sensitive biomarkers.
4.1. Effects of accumulated lead, cadmium, silver and uranium in the erythrocytes
At present there is lack of methods to describe the accumulated effects of metal ions in
erythrocytes in terms of stability constants or conditional constants. There is lacking informa‐
tion of e.g. solvent properties, pH, temperature, redox properties, lack of knowledge of
interacting compounds. Elemental profiles of erythrocytes may be an alternative to estimate
changes of trace elements and metal ions at the cellular level. The discussion below will be
focused on some effects on membrane integrity by lead, cadmium, silver and uranium because
it is not fully known how these ions are associated to other compounds.
4.2. Initiation of eryptosis by accumulated lead, cadmium silver and uranium in erythrocytes
It has been suggested that mature erythrocytes may enter programmed death without the aid
of caspase systems [15,16]. Heavy metal ions and organic compounds may be involved in early
senescence [17, 18, 19]. When erythrocytes are growing old they will change gradually,
fragments will be cleaned up [20, 21], mainly in spleen, liver, bone marrow by the macro‐
phages. Most material of captured senescent erythrocytes e.g. iron and metabolized organic
material will be reused [22, 23].
Silver, cadmium ions induce suicidal erythrocyte death [24, 25] and it is likely that erythro‐
cytes  and  cells  dependent  on  erythrocytes  of  patients  with  Alzheimer’s  disease  with
accumulated silver and also lead, cadmium and uranium may show early eryptosis. Eryptosis
may also  be  initiated  via  formation  of  phosphatidylserine  by  lead,  cadmium,  hemin  as
stimulator [26, 27, 28].
4.3. Erythrocyte channels exposed to accumulated ions of lead, cadmium, silver and uranium
The accumulated lead, cadmium, silver and uranium may interfere the activity in the eryth‐
rocyte channels for cations, anions and water. Cadmium, lead, silver may interfere with
potassium, calcium [29, 30] and other ions in erythrocyte membranes [31, 32]. Binding in vitro
of cadmium to β-amyloid channels was reported by [33]. Exposure to accumulated lead,
cadmium, silver, uranium ions to β-amyloid or other compounds is likely to support the
pathophysiological process by association to available binding sites.
Anions e.g. chlorides, carbonates ions are transported in anion channels [34, 35, 36] may react
with silver, lead, cadmium and uranium disturbing channel transport and oxygen handling.
Aquaporin channels in the erythrocyte membrane are important for flow of water and shape
[37,  38,  39].  Accumulated cadmium, lead,  silver,  uranium ions associated to  erythrocyte
aquaporin channels may decrease the capacity to shrink and expand. Water exchange may
also be important for osmotic regulation when the erythrocytes enter capillaries. It cannot
be  excluded  that  lead,  cadmium,  silver,  uranium  may  release  important  elements.  e.g.
calcium from their association sites. Released calcium may form non-selective channels in
membranes [40].
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4.4. Accumulated cadmium, lead, silver and uranium ions may compete with essential
elements in carrier systems
Cadmium is known to compete with zinc in e.g. metallothionein (MT), carrier of zinc. Metal
ions having higher affinity than zinc may interact with the binding sites in MT or other carrier.
Lead and uranium ions is known to compete with calcium metabolism. Magnesium and
calcium ions in calmodulin (calcium carrier) may be displaced by accumulated lead, cadmium,
silver, uranium ions and release essential elements e.g. Mg, Ca, Zn. Release of secondary
messenger e.g. Mg may disturb ATP metabolism, Ca may activate translocases flippases,
floppases, scramblases and start apoptosis signals. Ca may also activate platelets and make
them sticky, ready for clot. Sticky platelets may associate to proteins and form placks.
4.5. Sources of cadmium, lead, silver and uranium — Food and implants
The food intake is not known for individual patients. In Finland cadmium uptake from food
is about 5-10 μg/day, lead 20-66 μg /day, uranium and, silver was not mentioned [41]. In
Sweden is reported cadmium uptake from wheat, rice, potatoes, root-crops 10-20 μg /day, lead
15-30 μg /day, uranium 1-4 μg /day, silver not indicated [42]. Cd uptake from nutrition may
disturb the heme synthesis. Cadmium rich diet in Nigeria decreased Hb and erythrocyte counts
in mice [43]. It cannot be excluded that cadmium, lead, silver, uranium contaminated food may
accumulate in human erythrocytes and in similar manner decrease erythrocyte counts and
hemoglobin synthesis. Smoker may have higher cadmium values in blood but there was no
information about smoking habits. Elevated uranium in drinking water may damage the
kidneys and increase protein loss in urine [44, 45].
In Finland some districts have drinking water with high uranium concentrations (> 100 μg/L)
which together with cadmium, lead and silver may increase kidney damage and disturb
erythrocyte metabolism. Uranium in the drinking water may explain the significant elevated
uranium concentrations of erythrocytes of Alzheimer patients.
Implants may be a source of metal ion supply. Amalgam is an alloy which is not stable [2, 3,
46, 47, 48] (release mercury, silver). Guttapercha may sometime contain cadmium [2] but the
released amount is not known for the examined patients. Mercury was not analyzed as
mercury will associate strong to liver, kidney also to pituary, low mercury will be found in
blood. Mercury has also capacity to displace secondary messenger e.g. Mg, Ca, Zn, Fe when
not properly associated.
4.6. Elemental profiles of erythrocytes as biomarkers of Alzheimer’s disease by ICP-MS
The early diagnosis of a neurological disease like Alzheimer’s and Parkinson’s disease is
difficult. In Parkinson’s disease about 25 % of the patients may get wrong diagnosis [49]. The
present study indicate that the elemental profile of erythrocytes may be used as a support in
the diagnosis and pathophysiology of Alzheimer’s disease. Changes in the elemental profile
should be possible to identify earlier due to high sensitivity of ICP-MS. Monitoring elements
in the erythrocytes may also be used to observe effects of applied pharmacy and effects on
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secondary messengers. More research is needed to interpret early symptoms of Alzheimer
disease and pathophysiological processes.
5. Conclusions
Monitoring changes of elements in the erythrocytes by ICP-MS may be used as an early
biomarker  of  Alzheimer’s  disease  and  may  support  the  pharmaceutical  treatment.  The
accumulated lead, cadmium, silver and uranium may interfere with channel activities, have
effects  on  apoptosis,  react  with  secondary  messenger  and  support  pathophysiological
processes.
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